(November 8, 2017, 10:56 AM EST) -- NEWARK, N.J. — The transfer of three securities class action lawsuits against a pharmaceutical company and certain of its executive officers to Massachusetts federal court is warranted because the necessary private and public interest factors weigh in favor of transfer, a federal judge in New Jersey ruled Oct. 27 in granting the defendants’ motion (Thomas Gallagher v. Ocular Therapeutix Inc., et al., No. 17-5011, D. N.J.; Dylan Caraker v. Ocular Therapeutix Inc., et al., No. 17-5095; Shawna Kim v. Ocular Therapeutix Inc., et al., No. 17-5704, D. N.J., 2017 U.S. Dist. LEXIS 179453)....